Improving cancer care while reducing its carbon footprint: GHG-mitigating strategies highlighted at ESMO 2025
がん治療の改善とカーボンフットプリント削減：ESMO 2025で注目された温室効果ガス排出削減戦略 (AI 翻訳)
Matthieu Delaye, Paul Matte, Anthony Turpin, Coline Ducrot, Sarah Dumont, Pierre-Florent Petit, Max Piffoux
🤖 gxceed AI 要約
日本語
本論文は、ESMO 2025で発表された約3000の抄録から、癌治療において温室効果ガス排出を削減する戦略を特定した。治療の強度や頻度を下げる10のアプローチが選ばれ、それぞれの排出量を推定。いずれも臨床成績を損なわず、一部は改善された。このような研究に環境影響評価を統合する必要性を提言。
English
This paper reviews abstracts from ESMO 2025 to identify cancer care strategies that reduce greenhouse gas emissions. Ten approaches, including treatment de-escalation and reduced drug use, were analyzed using the ECOVAMED database. All showed non-inferior or improved outcomes while lowering emissions. The authors advocate integrating environmental endpoints into clinical research.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
日本でも医療分野の脱炭素化が課題となる中、本論文は臨床試験の結果を活用して環境負荷低減と患者アウトカム改善を両立する方法を示す。日本の癌治療ガイドラインや医療制度への応用が期待される。
In the global GX context
Healthcare emissions constitute a significant share of global carbon footprint, yet clinical research rarely considers environmental impact. This paper demonstrates that systematic review of major oncology congresses can identify decarbonization opportunities without compromising care quality—a lesson directly applicable to global clinical practice and research funding.
👥 読者別の含意
🔬研究者:Provides a methodology to identify GHG-reducing clinical strategies from existing research, relevant for oncology and sustainability researchers.
🏢実務担当者:Hospitals can use these strategies to reduce treatment-related carbon footprint while maintaining quality, aiding sustainability reporting.
🏛政策担当者:Highlights the need for environmental endpoints in clinical trials and healthcare decarbonization policies.
📄 Abstract（原文）
BACKGROUND: The environmental impact of cancer care is an emerging concern, yet therapeutic strategies that may incidentally reduce greenhouse gas (GHG) emissions remain poorly described. The 2025 ESMO Congress, where nearly 3000 abstracts were presented, offered an opportunity to identify clinically validated approaches that could lower the carbon footprint of oncology. METHODS: All abstracts from the 2025 ESMO Congress were reviewed. Studies suggesting meaningful downstream reductions in drug use, visit frequency, treatment duration, or overall care intensity were selected. For each, GHG emissions were estimated using the ECOVAMED drug carbon-footprint database and standard emission factors. RESULTS: Ten abstracts were identified. They spanned primary prevention, therapeutic de-escalation, reduced dose or duration of systemic therapy, biomarker-guided treatment selection, and non-pharmacological interventions. Several strategies demonstrated non-inferior or improved clinical outcomes while substantially lowering treatment-related emissions. Notably, none of the selected studies had explicitly assessed environmental impact. CONCLUSIONS: Multiple strategies presented at ESMO 2025 appear capable of improving patient outcomes while reducing the environmental burden of cancer care. Systematically integrating environmental endpoints into clinical research would help identify such win-win approaches and advance a more sustainable oncology practice.
🔗 Provenance — このレコードを発見したソース
- openalex https://doi.org/10.1038/s44276-026-00231-zfirst seen 2026-06-17 05:50:01 · last seen 2026-06-17 07:14:10
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録（無料・3キーワードまで）。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。